Among patients with early-stage triple-negative breast cancer, a beneficial pathologic complete response rate was higher in ...
Hosted on MSN18d
BRCA1 gene mutations may not be key to prostate cancer initiation, as previously thoughtGermline BRCA 1 and BRCA 2 test results were available for all 450 men. These revealed 27 germline BRCA2 variants (6%), but only two germline BRCA1 variants (0.5%), and one of these probably wasn ...
Poly adenosine diphosphate-ribose polymerase (PARP) inhibitors, a class of targeted anticancer therapies, prevent genetic ...
Germline BRCA 1 and BRCA 2 test results were available for all 450 men. These revealed 27 germline BRCA2 variants (6%), but only 2 germline BRCA1 variants (0.5%), and one of these probably wasn't ...
Dr. Chandler Park sat down for an interview with CURE® to discuss the biggest takeaway from the 2025 ASCO GU Symposium in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback